
Sigachi Industries Limited Reaches Major R&D Breakthrough in Cystic Fibrosis API Development
Sigachi Industries Limited has announced a significant advancement in its research and development program with

Sigachi Industries Limited has announced a significant advancement in its research and development program with

Sigachi Industries Ltd (NSE: SIGACHI; BSE: 543389), a global manufacturer of pharmaceutical excipients and active

Sigachi Industries Ltd, a global leader in pharmaceutical excipients and active pharmaceutical ingredients (APIs), announced

Sigachi Industries Limited, a major Indian manufacturer of pharmaceutical excipients, active ingredients, and specialty compounds,

Sigachi Industries Limited, a prominent name in the pharmaceutical excipients, APIs, and specialty ingredients sector,